| Literature DB >> 19891898 |
Meera A Chand, Joanna S Herman, David G Partridge, Kirsten Hewitt, Peter L Chiodini.
Abstract
Entities:
Mesh:
Year: 2009 PMID: 19891898 PMCID: PMC2857236 DOI: 10.3201/eid1511.090511
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Characteristics of human fascioliasis case-patients during enhanced surveillance, United Kingdom, January 1, 2008–January 31, 2009*
| Case no. | Age, y/sex | Country of origin | Years since migration | Other travel | Risk factor | Clinical features | Eosinophil count, x109/L) | Abnormal liver function | Hepatic imaging | IFAT† |
| 1 | 45/F | Yemen | 7 | Yemen regularly | Abdominal pain | 8.4 | Yes | Mixed-density liver lesion (CT) | 1:128 | |
| 2 | 44/M | Somalia | 16 | Ethiopia 2007 | Fever, abdominal pain | 3.4 | Yes | Serpiginous lesion (MRI) | 1:64 | |
| 3 | 34/F | Ethiopia | 3 | S. Africa regularly | Fever, abdominal pain | 11.4 | No | Heterogeneous lesion (USS) | 1:128 | |
| 4 | 44/F | Somalia | 7 | Somalia 2004, Netherlands | Abdominal pain | 8.3 | No | Heterogeneous lesion (USS) | 1:128 | |
| 5 | 54/F | Somalia | 21 (to Netherlands), 4 (to UK) | None | Anorexia | 8.4 | No | Low-density lesion (CT) | 1:32 | |
| 6 | 43/M | Somalia | 28 (to India), 21 (to UK) | None | Fever | 1.0 | Yes | Heterogeneous lesion (USS) | 1:128 | |
| 7 | 28/F | UK | – | Uganda 2007–2008 | – | Abdominal pain, hepatomegaly | 1.84 | Yes | Hepatomegaly with large mixed cystic and solid lesion (USS) | 1:512 |
| 8 | 67/M | UK | – | Kenya 2008, prior world travel | – | Malaise, abdominal pain | 0.04 | Yes | Multiple gallstones (MRCP) | 1:256 |
| 9 | 38/M | Ethiopia | 10 | Ethiopia 2006 | – | Abdominal pain, fever | 18.7 | Yes | Normal (USS, MRCP) | 1:128 |
| 10 | 28/M | Ethiopia | Unknown | Unknown | – | Fever, gram- negative sepsis; new HIV diagnosis | <0.04 | Yes | Lesion in hepatic vein | 1:64 |
| 11 | 47/F | Somalia | 16 (to Yemen), 6 (to UK) | Unknown | Abdominal pain, fever | 16.8 | Yes | Low-density lesion (CT) | 1:256 |
*IFAT, immunofluorescent antibody test; CT, computed tomography; MRI, magnetic resonance imaging; USS, ultrasound scan, MRCP, magnetic resonance cholangiopancreatography. †Titer of IFAT (screening titer 32).